- Home
- VGI vs STIM Comparison
VGI vs STIM Comparison
Compare VGI & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VGI
- STIM
- Stock Information
- Founded
- VGI 2012
- STIM 2003
- Country
- VGI United States
- STIM United States
- Employees
- VGI N/A
- STIM N/A
- Industry
- VGI Investment Managers
- STIM Medical/Dental Instruments
- Sector
- VGI Finance
- STIM Health Care
- Exchange
- VGI Nasdaq
- STIM Nasdaq
- Market Cap
- VGI N/A
- STIM 221.8M
- IPO Year
- VGI N/A
- STIM 2018
- Fundamental
- Price
- VGI $7.74
- STIM $3.66
- Analyst Decision
- VGI
- STIM Buy
- Analyst Count
- VGI 0
- STIM 4
- Target Price
- VGI N/A
- STIM $6.00
- AVG Volume (30 Days)
- VGI 46.0K
- STIM 1.1M
- Earning Date
- VGI 01-01-0001
- STIM 08-11-2025
- Dividend Yield
- VGI 12.66%
- STIM N/A
- EPS Growth
- VGI N/A
- STIM N/A
- EPS
- VGI N/A
- STIM N/A
- Revenue
- VGI N/A
- STIM $89,448,000.00
- Revenue This Year
- VGI N/A
- STIM $105.22
- Revenue Next Year
- VGI N/A
- STIM $11.89
- P/E Ratio
- VGI N/A
- STIM N/A
- Revenue Growth
- VGI N/A
- STIM 22.16
- 52 Week Low
- VGI $6.68
- STIM $0.52
- 52 Week High
- VGI $7.99
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- VGI 45.70
- STIM 50.67
- Support Level
- VGI $7.70
- STIM $3.53
- Resistance Level
- VGI $7.87
- STIM $4.00
- Average True Range (ATR)
- VGI 0.07
- STIM 0.24
- MACD
- VGI -0.02
- STIM 0.05
- Stochastic Oscillator
- VGI 14.81
- STIM 61.80
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.